Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Valent

Showing results (201-210 of 662) with videos related to

Pageof 67
Sort By:
The American Journal of Pathology|May 10, 2002
Increased angiogenesis in the bone marrow of patients with systemic mastocytosisFriedrich Wimazal, John-Hendrik Jordan, Wolfgang R Sperr, et al.
Cell Research|May 27, 2005
Identification of CD13, CD107a, and CD164 as novel basophil-activation markers and dissection of two response patterns in time kinetics of IgE-dependent upregulationFlorian Hennersdorf, Stefan Florian, Andreas Jakob, et al.
Seminars in Cancer Biology|August 14, 2019
Redistribution, homing and organ-invasion of neoplastic stem cells in myeloid neoplasmsPeter Valent, Irina Sadovnik, Gregor Eisenwort, et al.
Leukemia|May 6, 2018
Implications of STAT3 and STAT5 signaling on gene regulation and chromatin remodeling in hematopoietic cancerBettina Wingelhofer, Heidi A Neubauer, Peter Valent, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 28, 2010
Aberrant expression of CD30 in neoplastic mast cells in high-grade mastocytosisKarl Sotlar, Sabine Cerny-Reiterer, Karina Petat-Dutter, et al.
The Journal of Allergy and Clinical Immunology|February 22, 2026
Soluble FcεRI is increased in advanced-mastocytosis and acts as negative-regulator of mast cell-expansion and activationGabriele Stefanzl, Sonja Kopanja, Daniel Ivanov, et al.
The Journal of Allergy and Clinical Immunology|March 15, 2015
Antibody conjugates bispecific for intercellular adhesion molecule 1 and allergen prevent migration of allergens through respiratory epithelial cell layersChristoph Madritsch, Julia Eckl-Dorna, Katharina Blatt, et al.
Expert Review of Hematology|January 3, 2018
Diagnosis, management and response criteria of iron overload in myelodysplastic syndromes (MDS): updated recommendations of the Austrian MDS platformPeter Valent, Reinhard Stauder, Igor Theurl, et al.
Leukemia Research|July 23, 2008
Lenalidomide therapy in systemic mastocytosisHanneke C Kluin-Nelemans, Veronika Ferenc, Jaap J van Doormaal, et al.
Leukemia Research|April 12, 2003
Aggressive systemic mastocytosis and related mast cell disorders: current treatment options and proposed response criteriaPeter Valent, Cem Akin, Wolfgang R Sperr, et al.
Pageof 67

Showing results (201-210 of 662) with videos related to

Sort By:
Pageof 67
The American Journal of Pathology|May 10, 2002
Increased angiogenesis in the bone marrow of patients with systemic mastocytosisFriedrich Wimazal, John-Hendrik Jordan, Wolfgang R Sperr, et al.
Cell Research|May 27, 2005
Identification of CD13, CD107a, and CD164 as novel basophil-activation markers and dissection of two response patterns in time kinetics of IgE-dependent upregulationFlorian Hennersdorf, Stefan Florian, Andreas Jakob, et al.
Seminars in Cancer Biology|August 14, 2019
Redistribution, homing and organ-invasion of neoplastic stem cells in myeloid neoplasmsPeter Valent, Irina Sadovnik, Gregor Eisenwort, et al.
Leukemia|May 6, 2018
Implications of STAT3 and STAT5 signaling on gene regulation and chromatin remodeling in hematopoietic cancerBettina Wingelhofer, Heidi A Neubauer, Peter Valent, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 28, 2010
Aberrant expression of CD30 in neoplastic mast cells in high-grade mastocytosisKarl Sotlar, Sabine Cerny-Reiterer, Karina Petat-Dutter, et al.
The Journal of Allergy and Clinical Immunology|February 22, 2026
Soluble FcεRI is increased in advanced-mastocytosis and acts as negative-regulator of mast cell-expansion and activationGabriele Stefanzl, Sonja Kopanja, Daniel Ivanov, et al.
The Journal of Allergy and Clinical Immunology|March 15, 2015
Antibody conjugates bispecific for intercellular adhesion molecule 1 and allergen prevent migration of allergens through respiratory epithelial cell layersChristoph Madritsch, Julia Eckl-Dorna, Katharina Blatt, et al.
Expert Review of Hematology|January 3, 2018
Diagnosis, management and response criteria of iron overload in myelodysplastic syndromes (MDS): updated recommendations of the Austrian MDS platformPeter Valent, Reinhard Stauder, Igor Theurl, et al.
Leukemia Research|July 23, 2008
Lenalidomide therapy in systemic mastocytosisHanneke C Kluin-Nelemans, Veronika Ferenc, Jaap J van Doormaal, et al.
Leukemia Research|April 12, 2003
Aggressive systemic mastocytosis and related mast cell disorders: current treatment options and proposed response criteriaPeter Valent, Cem Akin, Wolfgang R Sperr, et al.
Pageof 67